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Summary Several studies carried out during the past two decades have investigated the effect of dietary and
surgical manipulation on pancreatic growth and carcinogenesis. Diets high in trypsin inhibitor stimulate
pancreatic growth and increase the formation of preneoplastic lesions and carcinomas in the rat pancreas.
Cholecystokinin (CCK) is the key intermediary in this response, since both natural and synthetic trypsin
inhibitors increase circulating levels of the hormone and CCK antagonists largely prevent these changes. Fatty
acids enhance pancreatic carcinogenesis in both rats and hamsters, whereas protein appears to have a
protective role in the rat, but to increase tumour yields in the hamster. Several surgical operations affect the
pancreas. Pancreatobiliary diversion and partial gastrectomy stimulate pancreatic growth and enhance car-
cinogenesis, probably by means of increased CCK release. Complete duodenogastric reflux has similar effects
on the pancreas but the gut peptide involved is gastrin. Although massive small bowel resection increases
pancreatic growth, the marked reduction in caloric absorption probably explains its failure to enhance
carcinogenesis. CCK and enteroglucagon might work in concert to modulate the tropic response of the
pancreas to small bowel resection. In the pancreas, as in the large intestine, hyperplasia appears to precede and
predispose to neoplasia.
Among the common gastrointestinal cancers, adenocarcin-
oma of the pancreas offers a particularly poor prognosis,
rivalled only by adenocarcinoma of the gallbladder. The
incidence of pancreatic cancer has doubled in Western
Europe and more than quadrupled in Japan over the past 40
years (Gordis & Gold, 1984; Muir et al., 1987; Fontham &
Correa, 1989; Hirayama, 1989). Leaving aside the uncommon
cystic and neuroendocrine tumours, the overall cure rate for
'ordinary' (ductal) carcinoma is barely 1%. This tumour has
a number of unfavourable features: an uncertain aetiology,
an aggressive biological behaviour, the lack of an obvious
population to screen, and a delay in the onset of symptoms
so that metastasis has generally occurred by the time of
presentation (Williamson, 1988). Moreover, current treat-
ments are unsatisfactory. Ductal cancers seldom respond to
irradiation or chemotherapy and surgical resection involves a
major operation, even though the surgical risk has dimin-
ished sharply during the last decade (Watanapa & William-
son, 1992a). Sadly, postoperative recurrence is the norm with
5-year survival rates seldom exceeding 5%.
It is against this dismal background that aetiological
studies of pancreatic cancer assume a special importance; if
cure is so elusive, prevention should offer a more promising
tack. Epidemiological studies provide a few positive associa-
tions: increasing age, the male sex, a black skin, cigarette
smoking and possibly diabetes and alcoholism (Gordis &
Gold, 1984; Mills et al., 1988; Cuzick & Babiker, 1989). It
seems probable that dietary factors underlie the prevalence of
this disease in Western populations and that humoral mech-
anisms are involved. Various gastrointestinal hormones have
profound effects on the structure and function of the exo-
crine pancreas and thus might plausibly act as intermediaries
in pancreatic carcinogenesis.
In the large intestine and to a lesser extent in the small
bowel and stomach, we and other have shown that dietary or
surgical manipulations causing increased cell proliferation
will generally enhance experimental carcinogenesis, whereas
atrophy has a protective effect (Oscarson et al., 1979; Rainey
et al., 1983; Williamson & Rainey, 1984; Houghton et al.,
1987). The present review examines the hypothesis that
hyperplasia and neoplasia are similarly linked in the exocrine
pancreas. Since few data exist in man, we are primarily
concerned with events in rodent models of pancreatic car-
cinogenesis. Broadly speaking there are three types of model:
(1) Hamsters given BOP (N-nitrosobis (2-oxopropyl)amine)
and related nitrosamines develop ductal adenocarcinomas
that resemble the predominant histological pattern of 'spon-
taneous' human cancer (Pour et al., 1977; Scarpelli et al.,
1984).
(2) Rats given azaserine develop atypical acinar cell foci
(AACF) of acidophilic type which lead on to acinar cell
carcinomas (Longnecker, 1984). Although true acinar cell
carcinoma is rare in man, there is a substantial body of
evidence to suggest that acinar cells dedifferentiate to ductal/
ductular cells during the process of carcinogenesis (Flaks,
1984).
(3) Transgenic mice have been bred with a high incidence
of spontaneous development of pancreatic acinar cell tum-
ours and islet cell tumours (Ornitz et al., 1987; Longnecker et
al., 1990; Bell et al., 1991).
Effects of dietary manipulation (Table I)
Protease inhibitors
(1) Natural The discovery that diets containing raw soya
flour cause enlargement of the rat pancreas within 9 days
opened up the field of experimental pancreatic hyperplasia
and neoplasia (Rackis, 1965). Several subsequent studies have
shown that this pancreatic growth entails both hypertrophy
(increased protein and RNA content per unit DNA) and
hyperplasia (increased DNA content) (Folsch et al., 1974;
McGuiness et al., 1980; Crass & Morgan, 1982; McGuiness
et al., 1982; Oates & Morgan, 1982). In a long-term study,
McGuiness and colleagues (1980) compared the effects of
diets enriched with either raw or heated soya flour. With raw
soya, overt nodules appeared on the surface of the pancreas
after 30 weeks, 80% of rats had developed adenomas after 60
weeks and by 90 weeks, when median pancreatic weight was
nearly twice control, four of 26 survivors had invasive pan-
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Table I Summary of effects of dietary factors on pancreatic growth
and carcinogenesis
Effects on the pancreas
Species Growth Carcinogenesis
Trypsin inhibitor
- raw soya flour rat + +
mouse +
hamster +
- camostate rat + +
hamster + unknown
Fat rat + +
hamster +




Selenium rat + +
hamster +
Reduced caloric intake rat
+ = increase or stimulate, - = decrease or inhibit, = no effect,
*only in female animals, ± =inconsistent results, ?-= possibly
inhibit
creatic cancer. By contrast, heated soya did not increase
pancreatic weight, though one third of the rats had micro-
scopic hyperplastic nodules. Two other studies confirmed the
tropic effect of raw as opposed to heated soya flour (Crass &
Morgan, 1982; Oates & Morgan, 1982). Pancreatic hyperp-
lasia and accelerated cell proliferation were shown by greater
protein and nucleic acid contents plus increased thymidine
uptake; duct cell labelling was increased 11-fold and acinar
cell labelling two-fold. The heat-labile tropic factor was
thought to be soybean trypsin inhibitor (Rackis, 1965). When
plasma from rats fed 1.8-2.0% semipurified soybean trypsin
inhibitor was perfused through an isolated rat pancreas,
amylase secretion increased by a factor of two- to-three
(Khayambashi & Lyman, 1969). Feedback inhibition of pan-
creatic enzyme secretion by intraluminal trypsin is itself swit-
ched off by protease (trypsin) inhibitors (Green & Lyman,
1972). A humoral mechanism is involved (Green et al., 1973).
Circulating concentrations of cholecystokinin (CCK) are tre-
bled and concentrations of gastrin are increased by about
50% in rats fed raw soya flour (Adrian et al., 1982). Intra-
gastric instillation of soybean trypsin inhibitor causes a 30-
fold increase in circulating CCK (Liddle et al., 1984). Both
gastrin and CCK stimulate pancreatic growth in the rat
(Mainz et al., 1973; Brants & Morisset, 1976; Ihse et al.,
1976; Reber et al., 1977; Folsch et al., 1978; Peterson et al.,
1978; Dembinski & Johnson, 1979) and therefore seem likely
to mediate pancreatic growth after soybean feeding.
In rats at least, raw soya flour may also enhance car-
cinogenesis in the pancreas. A higher yield ofcarcinomas was
found in rats given the carcinogen di(2-hydroxypropyl) nitro-
samine (DHPN) (Levison et al., 1979). Using a different
pancreatic carcinogen (azaserine) in subthreshold doses, Mc-
Guiness and colleagues (1981) had a less clear-cut result. The
volume of neoplastic lesions in the rat pancreas was much
greater after feeding raw as opposed to heated flour, but the
proportion of affected animals with such lesions was similar
(65 vs 60%). Moreover, there are species differences. Mice
fed raw soya flour for 18 months had an enlarged pancreas
but were relatively resistant to the carcinogenic effects of
azaserine, whereas hamsters fed such diets for 15 months did
not exhibit pancreatic enlargement and had a low tumour
incidence (< 10%) after exposure to BOP (Liener & Hasdi,
1986). Pancreatic contents of DNA, RNA and protein were
unchanged by feeding raw soya flour to monkeys and were
almost unchanged in pigs (Struthers et al., 1983).
(2) Synthetic (camostate) Camostate, a synthetic guani-
dino acid ester, is a potent inhibitor of several enzymes:
trypsin, kallikrein, plasmin, thrombin, complement protein
(CI) esterase and phospholipase A2 (Muramatu & Fujii, 1972;
Tamura et al., 1977; Freise et al., 1983). Like soybean trypsin
inhibitor, camostate will increase circulating CCK concentra-
tions and stimulate pancreatic growth in rats when added to
the diet (Goke et al., 1986; Otsuki et al., 1987; Wisner et al.,
1988; Douglas et al., 1989; Douglas et al., 1990b). Treatment
with a specific CCK receptor antagonist, either L-364,718 or
CR-1409 (lorglumide), inhibits the tropic effect of camostate
on the pancreas (Wisner et al., 1988; Douglas et al., 1989;
Douglas et al., 1990b).
Again like the natural protease inhibitor, camostate mark-
edly increases the development of acidophilic AACF in rat
pancreas after azaserine administration, while CR-1409 inhi-
bits the hyperplasia and enhanced neoplasia (Douglas et al.,
1989). Similar pancreatic hyperplasia and hypercholecys-
tokininaemia follow camostate feeding in mice (Niederau et
al., 1987) and hamsters (Douglas et al., 1990b), but in ham-
sters CR-1409 treatment does not abrogate this response
(Douglas et al., 1990b). Thus both the natural and synthetic
protease inhibitors have somewhat different effects in differ-
ent species, and CCK also displays interspecies variations in
its action on the pancreas.
Fat
Diets rich in unsaturated fat, such as those containing corn
oil or safflower oil, enhance the development of pancreatic
neoplasms in the rat-azaserine model (Roebuck et al., 1981a
and 1981b). Likewise, administration of corn oil by gavage
(5-10 ml kg-' 5 days per week) causes a modest increase in
the yield of acinar cell nodules and adenomas compared with
standard chow (Boorman & Eustis, 1984). We have inves-
tigated the effects of individual fatty acids (stearic and oleic
acid) on the development of acidophilic AACF (the precur-
sors ofpancreatic carcinoma) (Khoo et al., 1991). Six months
after initiation with carcinogen the number and volumetric
indices of acidophilic AACF were increased in rats fed oleic
acid (but not stearic acid); examining total lipid extracts of
the pancreas showed a higher oleic acid content at the
expense of all other fatty acids in the pancreas. Roebuck and
colleagues showed an increase in the number and size of
acidophilic AACF as the EFA (essential fatty acid) content
of the diet was increased. (Roebuck et al., 1985). The
minimum proportion of dietary essential fatty acids required
for tumour enhancement lay in the range of 4 to 8%. Diets
rich in saturated fat (20% lard) will also enhance car-
cinogenesis, and this effect is not related to a higher caloric
intake (Appel et al., 1990). The concentrations of EFA used
in this study were 3% or less, and supplementation with the
EFA linoleic acid did not affect tumour yields in the low-fat
group.
High-fat diets and particularly those enriched with unsat-
urated fatty acids will also enhance the development of pan-
creatic cancer in the BOP-hamster model (Birt et al., 1981).
To avoid the effect of variation in total caloric intake, Birt
and colleagues (1989) conducted another experiment in which
high-fat diets (20.5% corn oil) were given either ad libitum or
by pair-feeding. Pair-fed hamsters receiving the high-fat diet
or a low-fat diet (4.3% corn oil) had equivalent calorie
intakes. Pancreatic carcinogenesis was increased two-to-four
fold when hamsters were fed a high-fat diet by either pro-
tocol, and the degree of enhancement did not differ with the
feeding regimen. As in rats, so in hamsters given BOP diets
high in saturated fatty acids (20% lard) enhance the forma-
tion of putative preneoplastic lesions (intermediate ductal
complex or tubular ductal complex) (Woutersen & van
Gerderen-Hoetmer, 1988).
Dietary fat can also affect the development of pancreatic
carcinomas in elastase 1-simian virus 40 T transgenic mice.
Animals fed either of the purified diets (containing 5% or
20% corn oil) developed a higher incidence of exocrine car-
cinomas than those fed how, but the level of fat in the diets
(5% vs 20%) did not alter tumour incidence (Longnecker et
al., 1990). Interestingly, male mice developed more exocrine
carcinomas than female mice and their tumours were larger,
but a higher incidence of islet cell tumours was found in
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The mechanism by which unsaturated fatty acids affect the
pancreas is uncertain. Intragastric feeding of various fats -
corn oil, beef tallow, fish oil and medium-chain triglycerides
- will each increase circulating CCK levels in rats (Douglas
et al., 1990a). However, since high-fat diets did not induce
pancreatic growth in one rat study (Roebuck et al., 1981b),
CCK may not act as a direct tropic influence on the pancreas
as it appears to do after administration of trypsin inhibitors.
Alternative mechanisms are (1) altered cell membrane or
receptor function owing to changes in the composition of cell
lipids or (2) involvement of pathways leading to prostaglan-
din synthesis (Longnecker, 1990).
Protein
Since the growth-stimulating properties of raw soya flour on
the pancreas are greatly increased by supplementing the diet
with essential amino acids (Booth et al., 1960), a lack of such
amino acids and nitrogen might ordinarily limit the response
to endogenous CCK. A recent study has explored the effects
of varying levels of protein consumption in rats with or
without exogenous CCK (caerulein) administration. Animals
received semipurified diets containing 5,30 or 60% casein for
14 days plus caerulein (2 jig kg-' s.c.) or vehicle for the last 4
days. Increasing the dietary protein content (without caeru-
lein) progressively increased pancreatic mass (wet weight,
nucleic acid and protein contents). Caerulein further in-
creased each growth parameter, but the maximal response
was achieved with 30% casein (Green et al., 1991).
Although the number of pancreatic neoplasms (adenomas
and carcinomas) at 1 year was reduced by a high-protein
(50% casein) diet in one experiment using the rat-azaserine
model (Roebuck et al., 1981a), the concentration of protein
chosen did not affect pancreatic weight. In the BOP-hamster
model, the incidence of pancreatic carcinomas did increase
with rising levels of dietary protein (at least in females), when
either 9% or 36% protein was given during the postinitiation
phase ofcarcinogenesis (Pour & Birt, 1983). There appears to
be some interaction between dietary levels of protein and fat,
since a high protein diet will not enhance pancreatic car-
cinogenesis when the fat content is low (Birt et al., 1983b).
These data are consistent with the finding that dietary pro-
tein and CCK work synergistically to stimulate pancreatic
growth.
Other specific dietary constituents
Retinoids Various types of retinoid will inhibit azaserine
carcinogenesis in rats. There are fewer acidophilic AACF at 4
months (Roebuck et al., 1984) and fewer frank neoplasms at
1 year after initiation (Longnecker et al., 1982). However,
different retinoids have different efficacy. Thus retinylidene
dimedone, N-2-hydroxyethylretinamide and N-4-propionyl-
oxphyenylretinamide had a greater effect (at 1 year) than
N-4-carboxyphenylretinamide (Longnecker et al., 1982).
Hamsters generally tolerate retinoids poorly and lower doses
are required. This fact may explain the divergent reports of
their effects on pancreatic carcinogenesis, including greater
tumour yields (Birt et al., 19883a), reduced yields (Long-
necker et al., 1986) and unchanged yields (Longnecker et al.,
1983).
Selenium Reported data are inconsistent. In one experiment
selenium supplements (0.02, 0.2 or 2.0 p.p.m.) reduced the
number ofpreneoplastic lesions in the rat-azaserine model (at
4 months) at various levels of dietary fat content (O'Connor
& Campbell, 1984). In another experiment selenium (5.0
p.p.m.) had no such effect on established pancreatic tumours
at 1 year (Curphey et al., 1988). In the hamster-BOP model
the effect of selenium varies with sex and dose. In females
adenomas yields were progressively inhibited as selenium
supplements went up from 0 to 5.0 p.p.m. (Birt et al., 1986),
but paradoxically in males there were more carcinomas at
2.5 p.p.m. than 0.1 p.p.m. of selenium. Woutersen and van
Garderen-Hoetmer (1988) studied the effect of selenium on
pancreatic carcinogenesis in both male rats and hamsters fed
high fat diets (20% lard). Selenium did not affect the forma-
tion ofacidophilic AACF in rats. It decreased the number of
early ductal complexes in hamsters, but again in high concen-
tration it increased the number of carcinomas.
Total caloric intake
Most organs atrophy during starvation and the pancreas is
no exception. Fasting causes a progressive reduction in wet
weight, nucleic acid and protein contents in rats (Webster et
al., 1972; Brand & Morgan, 1981; Nagy et al., 1989), and
refeeding restores these indices of organ mass (Webster et al.,
1972). Cell proliferation is also impaired by fasting, with
decreased incorporation of tritiated thymidine into DNA (in
rat pancreas) at 48 h (Solomon, 1986). Roebuck and col-
leagues studied the effect of caloric intake on pancreatic
carcinogenesis in rats initiated with azaserine and found that
rats with caloric restriction (to 90% of control consumption)
had no pancreatic neoplasms at 7.5 months, while 24% of
controls had tumours (Roebuck et al., 1981b). Thus reduced
caloric intake will protect against experimental pancreatic
carcinogenesis as it does in many other organs. The underly- ing mechanism is unknown; reduced levels of carcinogen-
activating enzymes in the pancreas or reduced tropic stimuli
to the gland are plausible hypotheses (Longnecker, 1990).
Effects ofsurgical manipulation (Table II)
Several different operations have been shown to stimulate
pancreatic growth during the past decade, and some of them
enhance pancreatic carcinogenesis as well. Haegel and col-
leagues (1981) demonstrated pancreatic hyperplasia 2 weeks
after 90% small bowel resection in the rat. Confirming this
hyperplastic response to massive enterectomy, another group
of French workers investigated the intermediary role of gas- trin. A preliminary antrectomy reduced serum gastrin by 36%, yet the pancreas still adapted to small bowel resection
(Stock-Damge et al., 1984). We have explored the role of
three gut peptides that could mediate the pancreatic response
to small bowel resection: enteroglucagon, neurotensin and
cholecystokinin. Both 1 week and 1 month after 90% prox- imal small bowel resection, 5-72% increments in pancreatic
mass correlated with 83-150% increments in enteroglucagon
levels, while neurotensin levels were unchanged (Watanapa et
al., 1991a). CCK proved to be another candidate for the role
of pancreatotropin. Circulating levels were doubled 3 weeks
after massive enterectomy, and the specific CCK receptor
antagonist CR-1409 (lorglumide) completely prevented the
effect on pancreatic growth (Watanapa et al., 1992b).
The actions ofenteroglucagon and CCK are closely linked.
Enteroglucagon plays a major role in modulating the com-
pensatory hyperplasia seen in the remaining small bowel after
partial enterectomy (Bristol & Williamson, 1988). The duo-
denum participates in this adaptive response to proximal
small bowel resection (Williamson & Bauer, 1978; Urban et
Table II Summary of effects of surgical operations on pancreatic
growth and carcinogenesis
Effects on the pancreas
Species Growth Carcinogenesis
Proximal small bowel rat +
resection
Ileocaecal resection rat + unknown
Truncal vagotomy rat + unknown
hamster +
Gastrectomy rat + +
Split gastrojejunostomy rat + +
(duodenogastric reflux)
Cholecystectomy hamster +
Pancreatobiliary diversion rat + +
+ = increase or stimulate, ± = inconsistent results, *-. = no effect880 P. WATANAPA & R.C.N. WILLIAMSON
al., 1982). Should duodenal mucosal growth embrace the
enteroendocrine cells (that produce CCK), increased CCK
release might well ensue. Massive small bowel resection pro-
ves an exception to the general rule that pancreatic hyper-
plasia predisposes to neoplasia. The number of pancreatic
preneoplastic lesions was unchanged 6 months after a 90%
resection (Stewart et al., 1991), probably because severe
weight loss and malabsorption suppressed carcinogenesis
(Roebuck et al., 1981b). Thus the stimulatory effect of oper-
ation might be balanced by the inhibitory effect of caloric
restriction.
Ileocaecal resection produces hyperplasia and hypertrophy
in rat pancreas at 4 weeks (Baba et al., 1985). Again humoral
changes could be involved, but so could another mechanism,
namely a deficiency in the bile acid pool resulting from
interruption of the enterohepatic circulation. In support,
reducing luminal concentrations of bile acids either by ad-
ministering cholestyramine (a binding agent) or by ligating
the bile duct will increase pancreatic mass in rats (Brand &
Morgan, 1982; Baba et al., 1983). It has now been shown in
mice that giving oral cholestyramine (as a 4% dietary supple-
ment for 1 week) leads to an elevated plasma CCK level
while increasing pancreatic protein, RNA and DNA by
34-40% (Gomez et al., 1990). Moreover, all the tropic
effects of cholestyramine on the pancreas are completely
abolished by the administration of the specific CCK antag-
onist L-364,718. As for pancreatic carcinogenesis, a 2%
cholestyramine supplement will potentiate the action of aza-
serine (by increasing the yield ofacidophilic AACF) but only
in rats given heated soya flour and not raw flour (Morgan et
al., 1990).
Two independent groups from Germany have reported
pancreatic growth following truncal vagotomy in rats (Koop
et al., 1986; Buchler et al., 1987; Buchler et al., 1988). Koop
and colleagues found that basal gastrin was increased after
vagal section, but the levels did not correlate with the degree
of exocrine pancreatic hyperplasia (Koop et al., 1986). Biich-
ler and colleagues measured both basal and postprandial-
plasma CCK and gastrin; CCK levels were unchanged,
whereas basal and postprandial gastrin levels were increased
(Buchler et al., 1988). In the hamster, truncal vagotomy
enhances pancreatic carcinogenesis; changes in bile acid com-
position may be involved (Ogawa et al., 1991).
Gastrectomy, whether total or subtotal, will also produce
pancreatic hyperplasia with increased organ mass at 2-4
weeks (Malfertheiner et al., 1987; Biichler et al., 1988). In our
own study rats with 60% distal gastrectomy had more (and
larger) acidophilic AACF than controls 15 months after
exposure to azaserine. Unlike Malfertheiner, we found higher
plasma CCK concentrations, both basal and postprandial
(Watanapa et al., 1992e). Thus CCK could act as an
intermediary for the stimulatory effects ofpartial gastrectomy
on the pancreas, especially since antral resection would
reduce gastrin output.
If complete duodenogastric reflux is produced in rats by
means of a split gastrojejunostomy, numerous hyperplastic
nodules plus some adenomatous nodules develop in the pan-
creas approximately 1 year after the operation (Taylor et al.,
1989). We have further investigated the effect of duodenogas-
tric reflux on pancreatic growth and chemical carcinogenesis.
Six months after split gastrojejunostomy rats had greater
pancreatic weight, and only those with duodenogastric efflux
showed any preneoplastic foci after azaserine treatment
(Watanapa et al., 1992c). On this occasion plasma CCK
levels were unchanged, while both basal and postprandial
plasma gastrin levels were increased by split gastrojejun-
ostomy. In summary, both vagotomy and duodenogastric
reflux stimulate pancreatic growth in association with hyper-
gastrinaemia. Partial gastrectomy (which causes both partial
vagotomy and some degree of duodenogastric reflux) has a
similar effect on the pancreas, and this is mediated not by
gastrin but possibly by CCK.
Cholecystectomy has been reported to stimulate pancreatic
growth in hamsters and to increase plasma CCK concentra-
tions 2-4 weeks after the operation (Rosenberg et al., 1983;
Rosenberg et al., 1984). However, 30 weeks after initiation
with BOP, hamsters with cholecystectomy had similar pan-
creatic weights and tumour yields to unoperated controls
(Chester et al., 1989). Experimental diversion of pancrea-
tobiliary secretions to the mid small bowel (pancreatobiliary
diversion) in rats causes (1) hyperplasia of the mucosa of the
transposed jejunal segment (Miazza et al., 1992), (2) in-
creased plasma CCK concentrations and (3) marked and
sustained growth of the pancreas (Miazza et al., 1987). Long-
term pancreatobiliary diversion (PBD) causes nodule forma-
tion in the rat pancreas, both hyperplastic and adenomatous
nodules (Stace et al., 1987). PBD not only stimulates pan-
creatic acinar cell growth, but also increases the proliferative
activity of the ductular cells (Gasslander et al., 1991). Subse-
quent studies using a specific CCK receptor antagonist
(either CR-1409 or L-364,718) confirm a major role for CCK
in the adaptive response of the rat pancreas to PBD (Axelson
et al., 1990; Gasslander et al., 1990; Watanapa et al., 1991b).
In our own laboratory, 6 months after azaserine treatment
PBD greatly increased the incidence of pancreatic preneo-
plastic lesions and quadrupled circulating levels of CCK
(Stewart et al., 1991; Watanapa et al., 1992d). CR-1409 not
only inhibited the enhancing effect of PBD on pancreatic
carcinogenesis, but also reduced the stimulatory effect of the
operation on pancreatic growth (Watanapa et al., 1992d),
suggesting a positive relationship between pancreatic hyper-
plasia and neoplasia. It seems clear that PBD stimulates
pancreatic growth and enhances pancreatic carcinogenesis by
causing elevated plasma CCK levels. This hypercholecysto-
kininaemia could reflect either a lack of negative feedback
inhibition on CCK secretion once pancreatic juice is diverted
from the jejunum, or an increased CCK synthesis by hyper-
plastic enteroendocrine cells in the transposed jejunum.
Evidence in man
Dietaryfactors
The use of animal models has traditionally provided much
information on the aetiology of many cancers. Together with
epidemiological studies in man and in vitro experiments,
animal work is the third major source of such information.
In Japan, where the incidence of pancreatic cancer has more
than quadrupled over the past 40 years, the data suggest a
correlation with soybean intake (Hirayama, 1989). The rela-
tive risk ofpancreatic cancer for those who consume soybean
soup occasionally is 1.52, compared to 1.00 in those who
never consume it. The relative risk rises to 1.77 in those
taking soybean soup every day. Though most of the trypsin
inhibitor activity in some traditional Oriental soya foods is
removed or inactivated during processing and the remainder
is further reduced during cooking, the Japanese food 'miso' is
an exception. Miso is a fermented soya product used in
cooking, particularly in soups. It contains a high concentra-
tion of free fatty acids (39% as opposed to 0.5% in other
common soya products), which are believed to act as a
heat-stable trypsin inhibitor (the usual specific soybean tryp-
sin inhibitors are proteins) (Doell et al., 1981). CCK may
also be involved since raw soybean flour causes a nearly
four-fold increase in circulating CCK levels in man as
opposed to heat-treated flour (Calam et al., 1987). Total fat
intake has also been shown to correlate positively with mor-
tality rates from pancreatic cancer (Lea, 1967; Wynder et al.,
1973; Gordis & Gold, 1984) despite similar body weights
between controls and patients with pancreatic carcinoma
(Wynder et at., 1973).
Surgicaloperations
Mack and colleagues conducted an epidemiological survey in
490 pancreatic cancer patients treated in the Los Angeles
area of California (Mack et al., 1986). They found a strong
association between pancreatic cancer and a history of pre-
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vagotomy with pyloroplasty), with a relative risk factor of
7.0. Two subsequent epidemiological studies have confirmed
this positive link, showing a risk factor of 3.4 and 4.0
(Caygill et al., 1987; Mills et al., 1988). None of these three
reports distinguished between gastrectomy and vagotomy as
the causative factor. However, a case-control study on au-
topsy subjects showed a three-fold risk of pancreatic cancer
in postgastrectomy patients (Offerhaus et al., 1987). Schlag
and colleagues (1980) studied the effect of gastric operations
for peptic ulcer disease in 44 patients at least 2 years after the
operation. They demonstrated increased levels of nitrites and
n-nitroso compounds in the remaining stomach (after either
Billroth I and II resections), but these substances were not
increased after proximal gastric vagotomy, which preserves
the pyloric sphincter mechanism. Their subsequent study also
showed unchanged levels of these substances in unoperated
stomachs with atrophic gastritis (Schlag et al., 1982). Thus
partial gastrectomy and duodenogastric reflux seem to be
involved in n-nitrosation in the operated stomach. These
nitrites and n-nitroso compounds can act as pancreatic car-
cinogens. They could be absorbed and subsequently secreted
into the pancreatic juice or might reflux from the duodenum
into the pancreatic duct, thereby inducing pancreatic cancer.
These operations may increase pancreatic growth as a conse-
quence of hypercholecystokininaemia (after gastrectomy) or
hypergastrinaemia (after procedures that produce duodeno-
gastric reflux such as vagotomy with pyloroplasty). This
hyperplasia combined with greater exposure to pancreatic
carcinogens might explain the increase in pancreatic cancer
risk after peptic ulcer surgery.
A retrospective epidemiological study in 100 males and 42
females with pancreatic cancer demonstrated a positive rela-
tionship between pancreatic cancer and cholecystectomy in
females (Wynder et al., 1973). However, a subsequent study
failed to confirm this increased risk (Mack et al., 1986). A
massive small bowel resection is rarely performed in man,
and those who survive the operation might not live long
enough to develop pancreatic cancer (if there is any increased
risk). Therefore the relationship between enterectomy and
pancreatic cancer is still unknown, and no excess has been
reported after ileocaecal resection.
Multiple genetic events have been shown to be necessary
for neoplastic transformation, and several complementary
molecular abnormalities have been described in human pan-
creatic cancer. The Kirsten ras oncogene at codon 12, over-
expression of the epidermal growth factor receptor and
abnormalities of c-erbB-2 expression are demonstrated in
20-90% of patients with pancreatic cancer (Gullick et al.,
1987; Almoguera et al., 1988; Kloppel et al., 1989). In BOP-
induced pancreatic adenocarcinomas in hamsters, activation
of the c-Ki-ras by point mutation (G-A transitions of the
second base) has been reported in codon 12 and 13 (Cerny et
al., 1990; Fujii et al., 1990; van Kranen et al., 1991), but such
changes are not found in pancreatic tumours (including
adenomas, carcinomas in situ and adenocarcinomas) of rats
receiving azaserine (Schaeffer et al., 1990; van Kranen et al.,
1991). Therefore the data from carcinogenesis experiments
may only be of tentative relevance to the human situation.
However, the consistent effect of nutrient intake and some
common operations on pancreatic cancer risk in animals and
man would support further research in this area. Although
care must be taken in extrapolating from narrowly-focused
animal studies to free-living human populations, the car-
cinogenesis models do allow us to explore specific mechan-
isms in great detail. The fact that less is known about the
cause of pancreatic cancer than almost any other common
abdominal cancer is sufficient justification to continue this
exploration.
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